MET and gastric cancer: The heterogeneity may provide the opportunity for clonal evolution, and the intra-tumoral heterogeneous clonal evolution of signaling such as that by p-Smad2 and c-Met might be associated with the acquisition of lymph-node metastatic ability in gastric cancer cells.